Related Experiment Video
Updated: Mar 6, 2026

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.7K
Immunotherapy for food allergy
William R Reisacher1, Wesley Davison
1aDepartment of Otolaryngology, Head & Neck Surgery, Weill Cornell Medical College bNewYork-Presbyterian Hospital, New York, New York, USA.
Current Opinion in Otolaryngology & Head and Neck Surgery
|March 21, 2017
Summary
Specific immunotherapy (SIT) for food allergy is advancing, with sublingual, epicutaneous, and oral routes showing promise. Research is optimizing delivery methods to improve effectiveness and safety for routine clinical use.
Area of Science:
- Immunology
- Allergy Research
- Therapeutic Strategies
Background:
- Food allergy treatment is an evolving field.
- Specific immunotherapy (SIT) is gaining traction for managing food allergies.
- Understanding different administration routes and modifications is crucial.
Purpose of the Study:
- To review strategies for administering specific immunotherapy (SIT) for food allergy.
- To examine delivery routes, immunomodulatory adjuvants, and allergen modifications.
- To assess the current landscape and future directions of food allergy SIT.
Main Methods:
- Review of current literature on SIT for food allergy.
- Analysis of different administration routes: sublingual, epicutaneous, and oral immunotherapy.
- Evaluation of immunomodulatory adjuvants and allergen modifications.
Main Results:
- Sublingual immunotherapy (SLIT) is effective with a favorable safety profile.
- Epicutaneous immunotherapy (EPIT) is effective, particularly in children, with local reactions.
- Oral immunotherapy (OIT) shows high efficacy but carries risks of adverse events.
- Adjuvants and genetic modifications are being explored to enhance efficacy and safety.
Conclusions:
- SIT for food allergy is nearing clinical applicability.
- Ongoing research focuses on optimizing delivery methods for enhanced efficacy and reduced adverse events.
- Future studies will determine optimal dosing and maintenance strategies for sustained protection.
Related Concept Videos
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Allergic Reactions: Anaphylaxis
92
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
92
Allergic Reactions
33.1K
Overview
33.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Cross-reactivity
33.6K
Overview
33.6K

